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doi:10.1016/j.jmii.2011.09.011Staphylococcus lugdunensis is often misidentified as S aureus and as a rare cause of infective
endocarditis. The clinical course of S lugdunensis endocarditis is aggressive and the mortality
rate is high in contrast to S epidermidis endocarditis. Most reported cases of S lugdunensis
endocarditis have involved mitral or aortic valves. Herein, we present a case with isolated
tricuspid endocarditis due to S lugdunensis.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Staphylococcus lugdunensis is a gram-positive, coagulase-
negative staphylococcus that was first described by Freney
et al. in 1988.1 The species is a skin commensal that is
mostly found in the perineum.1 However, S lugdunensis
can also cause clinically significant infections, includings of Laboratory Medicine and
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an Society of Microbiology. Publendocarditis, septicemia, skin and soft tissue infection,
bone and joint infection, toxic shock syndrome, central
nervous system infection, peritonitis, and ocular infection.2
Endocarditis is the most devastating infection due to
S lugdunensis. In contrast to S epidermidis, S lugdunensis
endocarditis typically has an acute and aggressive clinical
course, similar to that caused by S aureus.3 Most native
valve endocarditis caused by S lugdunensis involves the
mitral valves, with tricuspid valve endocarditis being rare
and usually occurring after implantation of a pacemaker,4
a cardioverter defibrillato,5 or as part of multivalvular
involvement.6e8 We present a case of an isolated tricuspid
valve endocarditis caused by S lugdunensis that is unrelated
to the implantation of any medical device.ished by Elsevier Taiwan LLC. All rights reserved.
Figure 2. Transthoracic echocardiogram revealing a 2.0
2.9 cm shaggy mass on the tricuspid valve (arrow).
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On June 29, 2007, a man 67 years of age who had had with
intermittent fever for 2 weeks presented to the emergency
department of Far-Eastern Memorial Hospital, a tertiary
medical center in Taipei, Taiwan. The patient had type 2
diabetes mellitus that had been controlled by an oral
hypoglycemic agent for 10 years. He noted general malaise
for 1 month prior to admission and dry cough for 2 weeks.
He worked as a security guard and had an unremarkable
history of travel or animal exposure. The patient was
admitted on June 30, 2007.
On examination, the patient was alert and well
oriented. His vital signs were: respiratory rate, 24/min;
BP, 143/62 mmHg; temperature, 39.5C; and heart rate,
112 beats/min. On auscultation, crackles over the bilateral
lower lung fields were noted. Cardiac auscultation dis-
closed a grade 3 holosystolic murmur at the left lower
sternal border and apex, with left axillary radiation. A
hemogram indicated anemia (Hb 8.2 gm/dL), thrombocy-
topenia (57,000/mL), and leukocytosis (23,780/mL) with
neutrophilia (80%). Additional blood tests showed hyper-
bilirubinemia (total/direct bilirubin 2.0/0.83 mg/dL) and
elevated lactate dehydrogenase (549 U/L). A chest X-ray
showedmultisegmental consolidations, with bilateral pleural
effusion (Fig. 1). The initial diagnosis was pneumonia,
so levofloxacin was administered soon after admission.
However, he developed hypoxic respiratory failure and was
intubated on July 2, 2007.
Two sets of blood cultures that were obtained at admis-
sion yielded gram-positive cocci. Infective endocarditis was
suspected with a 2.0 2.9 cm shaggy mass on the tricuspid
valve with moderate regurgitation found by cardiac echo-
cardiography (Fig. 2). The isolate was initially identified as
oxacillinesusceptible S. aureus (OSSA). Isolated tricuspid
endocarditis due to OSSA with pulmonary septic embolism
was impressed. Empirical antimicrobial agents included
oxacillin, gentamicin, and ceftriaxone; gentamicin and cef-
triaxone were discontinued after 7 days of use.Figure 1. Initial chest X-ray showing multisegmental
consolidations with bilateral pleural effusion.Blood cultures that were obtained on July 10, 2007,
indicated persistent bacteremia with six sets of positive
blood cultures. Transesophageal echocardiography on July
11, 2007, found minor shrinkage of tricuspid vegetation
(2 2 cm). The isolate was reidentified as S lugdunensis
due to atypical colony morphology and hemolysis pattern
on the Trypticase soy agar supplemented with 5% sheep
blood (BBL Microbiology Systems, Cockeysville, MD USA). In
spite of a positive latex agglutination test, the results from
a tube coagulase test were negative.
Because of poor treatment response, persistent large
vegetation, and the presence of a virulent pathogen,
tricuspid valvular replacement with Hancock II biopros-
thesis was performed on July 11, 2007. During the opera-
tion, severe deformation of the valve, chordae, and
annulus, were noted. Microscopically, there were fibro-
purulent exudate and bacterial clumps. A tissue culture
yielded S lugdunensis. Shortly after surgery, the patient’s
fever subsided. He was extubated at 8 days after surgery,
and then transferred to a general ward on July 26, 2007.
However, a nosocomial infection complicated the patient’s
recovery and he died of severe sepsis on August 13, 2007.
Discussion
S lugdunensis, a gram-positive, nonmotile coccus, is
coagulase-negative, but some strains are positive for
a clumping factor by the slide-agglutination test.1 Thus,
S lugdunensis can be misidentified as S aureus. The tube
coagulase test can be used to distinguish S aureus and S
lugdunensis, and S lugdunensis can also bedistinguished from
other coagulase-negative staphylococci by the presence of
ornithine decarboxylase and pyrrolidone arylamidase. In
addition, S lugdunensis produces acid from trehalose,
mannose, maltose, and sucrose, but not mannitol.2,9 The
identification of S lugdunensis was supported by a negative
tube coagulase test and the presence of ornithine decar-
boxylase and pyrrolidone arylamidase, and this was
confirmed by the Phoenix Automated System (Becton Dick-
inson Diagnostic Systems, Sparks, MD USA).
250 K.-P. Chung et al.Possible sources of S lugdunensis infections include
vasectomy, scrotal wound, femoral angiography, arteriove-
nous fistula, or a venous catheter used for hemodialysis.10e13
Clinically, S lugdunensis endocarditis can occur in the native
valve, a prosthetic valve, or a pacemaker. From a clinical
study of nondrug users, S lugdunensis caused 0.8%, 1.5%, and
7.8% of endocarditis of the native valve, prosthetic valve,
and pacemaker lead, respectively.3 The mortality rate of
S lugdunensis endocarditis (50%) was higher than that for
S aureus (14.5%, p< 0.01) or S. epidermidis (20%, p< 0.04).3
Surgery was more frequently undertaken in patients with
S lugdunensis endocarditis (70%) than in those with S aureus
endocarditis (36.9%, p< 0.04). S lugdunensis endocarditis
involving native valves was typically acute onset (duration of
symptoms< 30 days) with frequent complications (e.g.,
heart failure, periannular abscess, and peripheral embo-
lism). Surgery would most likely improve the probability of
survival.3,9
It has been reported that up to 50% of patients with S
lugdunensis bacteremia had endocarditis.14 Moreover, all
cases of S lugdunensis bacteremia due to endocarditis were
community-acquired infections. In contrast, most cases of
nosocomial S lugdunensis bacteremia were related to the
presence of a catheter or other foreign devices. Thus, every
patient with community-acquired S lugdunensis bacteremia
should be carefully evaluated for endocarditis.
Current guidelines of surgical interventions for infective
endocarditis have mainly focused on the cases of left-sided
endocarditis.15,16 Conservative treatment was recom-
mended for right-sided endocarditis, except for the pres-
ence of persistent fever for more than 3 weeks, right heart
failure, paravalvular abscess, fungal endocarditis, or the
presence of a large vegetation (>1 cm).17 The presence of
large vegetations (>2 cm) has been associated with a poor
outcome.18 Most cases of S lugdunensis native valve endo-
carditis involved mitral or aortic valves, and surgery was
often indicated.9 Despite the fact that the present patient
had isolated tricuspid involvement, surgery was indicated
due to the uncontrolled infection and a large vegetation.
S lugdunensis endocarditis is associated with significant
morbidity and mortality. It is crucial to differentiate S
lugdunensis from other coagulase-negative staphylococci.
Early surgical intervention may be needed for S lugdunensis
endocarditis.References
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